AIIMS Delhi to start booster dose trial of intranasal Covid vaccine from Friday, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

India is yet to approve the use of intranasal vaccine against COVID-19, BBV154 developed by the Hyderabad based company., India is yet to approve the use of intranasal vaccine against COVID-19, BBV154 developed by the Hyderabad based company., , Read More